Annals of Pharmacotherapy

SJR Rank #6,718H-index: 129SJR: 0.815Best quartile: Q2APC: US$4,400
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Medicine (miscellaneous)Q2
  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Pharmaceutical Practices and Patient OutcomesPharmaceutical studies and practicesAntibiotics Pharmacokinetics and EfficacyPharmacological Effects and Toxicity StudiesMedication Adherence and ComplianceAtrial Fibrillation Management and OutcomesDrug-Induced Adverse ReactionsPharmacovigilance and Adverse Drug ReactionsPoisoning and overdose treatmentsPharmacy and Medical Practices

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025065130195260

Detailed Information

ISSN

1060-0280, 1542-6270

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.52

References per Document

25.06

Coverage

1981, 1983, 1985, 1987, 1990-2026

Scope

Annals of Pharmacotherapy is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. Research articles may report well-designed studies of medication effectiveness, adverse events, interactions, adherence, pharmacoeconomics, pharmacokinetics, pharmacogenomics, pharmacoepidemiology, informatics and use to positively impact patient care. Review articles may describe evidence-based comprehensive, critical and analytical assessments of specific important or controversial subjects. These would include reviews of new drugs, drug classes, therapeutic controversies, and the state-of-the-art strategies to enhance the treatment and prevention of diseases. Commentaries and Editorials may offer perspectives on diverse therapeutic or professional issues influencing health care, medicine and pharmacy.

Metrics from SCImago Journal Rank 2025. View on SCImago